In-Depth Analysis of the Monoclonal Antibodies Market Size & Share Report, 2029

Healthcarenews16 Apr, 2024Business

The global size of monoclonal antibody therapeutics market in terms of revenue was estimated to be worth USD 252.6 billion in 2024 and is poised to reach USD 497.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029. The monoclonal antibody therapeutics market is primarily driven by factors such as increasing prevalence of chronic diseases like cancer, autoimmune disorders, and infectious diseases. Technological advancements in antibody engineering and production processes also contribute significantly.

Recent Profiles

Lambertsen Filtenborg

Lambertsen Filtenborg

View Profile

188BET

188bet

View Profile

Harmon Dwyer

Harmon Dwyer

View Profile

Stallings Munck

Stallings Munck

View Profile

Lassiter Dale

Lassiter Dale

View Profile

thc vape australia

Thc Vape Australia

View Profile

Magnusson Welsh

Magnusson Welsh

View Profile

Nyholm Law

Nyholm Law

View Profile

Nash Storgaard

Nash Storgaard

View Profile

Swain Martens

Swain Martens

View Profile